Ligand-Based Molecular MRI: O-17 JJVCPE Amyloid Imaging in Transgenic Mice

Journal of Neuroimaging

Volumn 24, Issue 6, 2014, Pages 595-598

  Suzuki, Kiyotaka ^a   Igarashi, Hironaka ^a   Huber, Vincent J ^a   Kitaura, Hiroki ^a   Kwee, Ingrid L ^b   Nakada, Tsutomu ^a,b  

^a NIIGATA UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

17O; Amyloid; JJ vicinal coupling; PiB; Pittsburg compound B

Indexed keywords

AMYLOID BETA PROTEIN; HYDROXYL GROUP; PITTSBURG COMPOUND B O 17; PROTON; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; WATER; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; AMYLOID PROTEIN; ANILINE DERIVATIVE; OXYGEN; THIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL MEDICINE; COVALENT BOND; IMAGING SYSTEM; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ANIMAL; ANTIBODY SPECIFICITY; BRAIN; METABOLISM; PATHOLOGY; PROCEDURES; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

AMYLOIDOGENIC PROTEINS; ANILINE COMPOUNDS; ANIMALS; BRAIN; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; MOLECULAR IMAGING; ORGAN SPECIFICITY; OXYGEN ISOTOPES; RADIOPHARMACEUTICALS; THIAZOLES; TISSUE DISTRIBUTION;

EID: 84939254618     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12091     Document Type: Article

References (15)

1. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy- 2-fluoro-D-mannose and C-14-2-deoxy-2-fluoro-D-glucose. J Labelled Compounds Radiopharm 1978;14:175-182.
2. Luyten PR, Marien AJ, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990;176:791-799.
3. Maudsley AA, Darkazanli A, Alger JR, et al. Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR Biomed 2006;19:492-503.
4. Nakada T, Kwee IL. Heterogeneity of regional cerebral glucose metabolism demonstrated in situ by 19F FDG NMR rotating frame zeugmatography: one dimensional chemical shift imaging of normal and gliosarcoma implanted brain. Magn Reson Imaging 1987; 5:259-266.
5. Nakada T, Kwee IL, Card PJ, et al. 19-Fluorine NMR imaging of glucose metabolism. Magn Reson Med 1988;6:307-313.
6. Nakada T, Kwee IL, Griffey BV, et al. 19F NMR glucose metabolic imaging in rabbit. Radiology 1988;168:823-825.
7. Nakada T, Kwee IL, Griffey BV, et al. 19F 2-FDG NMR imaging of the brain in rat. Magn Reson Imaging 1988;6:633-635.
8. Zhu X-H, Zhang N, Zhang Y, et al. In vivo 17O NMR approaches for brain study at high field. NMR Biomed 2005;18:83-103.
9. Nakada T. Grant-in-Aid for Scientific Research: magnetic resonance molecular microimaging. ww.jsps.go.jp/j-grantsinaid/12_kiban/ichiran_21/e.../e07_nakada.pdf
10. Mathis CA, Wang Y, Holt DP, et al. Synthesis and evaluation of C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 2003;46:2740-2754.
11. Oakley H, Cole SL, Logan S, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006;26:10129-10140.
12. Castleman KR. Digital image processing. Prentice Hall 1996;462-464.
13. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-319.
14. Johnson KA. Amyloid imaging of Alzheimer's disease using Pittsburgh Compound B. Curr Neurol Neurosci Rep 2006;6:496-503.
15. Snellman A, Rokka J, Lopez-Picon FR, et al. Pharmacokinetics of [18F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease. Eur J Nucl Med Mol Imag 2012;11:1784-1795.